Phospholipid-Membrane-Based Nanovesicles Acting as Vaccines for Tumor Immunotherapy: Classification, Mechanisms and Applications.

Abstract

Membrane vesicles, a group of nano- or microsized vesicles, can be internalized or interact with the recipient cells, depending on their parental cells, size, structure and content. Membrane vesicles fuse with the target cell membrane, or they bind to the receptors on the cell surface, to transfer special effects. Based on versatile features, they can modulate the functions of immune cells and therefore influence immune responses. In the field of tumor therapeutic applications, phospholipid-membrane-based nanovesicles attract increased interest. Academic institutions and industrial companies are putting in effort to design, modify and apply membrane vesicles as potential tumor vaccines contributing to tumor immunotherapy. This review focuses on the currently most-used types of membrane vesicles (including liposomes, bacterial membrane vesicles, tumor- and dendritic-cell-derived extracellular vesicles) acting as tumor vaccines, and describes the classification, mechanism and application of these nanovesicles.

• Authors: Wenjuan Chen, Yali Wu, Jingjing Deng, Zimo Yang, Jiangbin Chen, Qi Tan, Mengfei Guo, Yang Jin
• Journal: Pharmaceutics (Pharmaceutics) Vol. 14 Issue 11 (Nov 11 2022) ISSN: 1999-4923 [Print] Switzerland
• PMID: 36432636 (Publication Type: Journal Article, Review)